Developing epigenetic cancer therapies that modulate abnormal genes.
Industry: Health Care
First Day Return: -23.3%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 06/22/2018 |
Offer Price | $15.00 |
Price Range $14.00 - $16.00 | |
Offer Shares (mm) | 4.0 |
Deal Size ($mm) | $60 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 07/18/2018 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $60 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Cambridge, MA, United States |
Founded | 2008 |
Employees at IPO | 64 |
Website www.constellationpharma.com |